Amgen Inc. (AMGN)

$ 295.54
   
  • Change Today:
    $1.42
  • 52 Week High: $328.35
  • 52 Week Low: $258.59
  • Currency: US Dollars
  • Shares Issued: 536.90m
  • Volume: 1,504,255
  • Market Cap: $158,675m
  • RiskGrade: 100

Latest ShareCast News

EU approves AstraZeneca's Tezspire to treat nasal conditions

By Frank Prenesti

Date: Monday 22 Sep 2025

(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Amgen Inc. Market Data

Currency US Dollars
Share Price $ 295.54
Change Today $ 1.42
% Change 0.48 %
52 Week High $328.35
52 Week Low $258.59
Volume 1,504,255
Shares Issued 536.90m
Market Cap $158,675m
RiskGrade 100

Trades for 07-Oct-2025

Time Volume / Share Price
15:59 100 @ $295.41
15:59 100 @ $295.40
15:59 115 @ $295.40
15:59 100 @ $295.41
15:59 100 @ $295.41

Top of Page